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Abstract Fusion of different imaging modalities has gained
increasing popularity over the last decade. However, most
fusions are done between static rather than dynamic images.
In order to adequately visualize the complex three-
dimensional structures of the beating heart, high-temporal
and spatial image resolutions are mandatory. Currently, only
the combination of transesophageal echocardiography with
fluoroscopy allows real-time image fusion of high quality dur-
ing structural heart disease (SHD) interventions. The use of
markers as well as real-time image overlay greatly facilitates
communication between SHD team members and potentially
increases procedural success while reducing radiation dose
and use of contrast. However, to date there is only limited
evidence that fusion imaging improves safety and outcomes
of SHD interventions. This review highlights the benefits of
fusion imaging during SHD interventions such as transseptal
puncture and closure of atrial septal defects and left atrial
appendage as well as interventions on the mitral and aortic
valve.
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Background
Clinically significant valvular heart disease increases with ad-
vancing age, reaching a prevalence of 11.7 % of those aged
75 years or older [1]. Surgery is indicated in many of these
patients, but the perioperative mortality and morbidity risk in-
creases in this aging and often comorbid population [2].
Numerous less invasive therapies such as percutaneous or trans-
catheter interventions have recently been introduced for treat-
ment of structural heart disease (SHD). Transcatheter aortic valve
replacement (TAVR) has proven to be equally or more effective
than surgical aortic valve replacement for high-risk surgical pa-
tients [3, 4]. New devices effectively close the left atrial append-
age and thus reduce the risk of thromboembolic complications in
atrial fibrillation and even reducemortality [5].More than 18,000
patients with mitral regurgitation have been treated for moderate
to severe mitral regurgitation by percutaneous mitral valve repair
using the MitraClip device (Abbott Vascular, Santa Clara, CA)
[6, 7]. And already new transcatheter options such as percutane-
ous mitral annuloplasty ring implantation or transcatheter mitral
valve replacement appear on the horizon [8, 9].
Historically, interventional cardiologists work with fluoros-
copy as the main tool for real-time guidance of catheter-based
therapy. However, one of the key factors in the tremendous
success of SHD interventions is the ongoing development and
clinical implementation of advanced cardiac imaging [10].
Since interventions in structural heart disease are performed
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on the beating heart, visualization of the relevant structures
with means other than direct visual inspection by the surgeon
is crucial. Advances in cardiac imaging with three-
dimensional (3D) transesophageal echocardiography (TEE)
and multislice computed tomography (MS CT) have proven
particularly helpful in demonstrating the complex valvular
morphology and in performing necessary pre-interventional
precise measurements for planning and tailoring of percutane-
ous therapies [11, 12]. Up to now, images during SHD inter-
ventions are displayed on several screens, thus requiring ex-
tensive effort of coordination and communication between
imagers and interventionalists.
Fusion imaging projects echocardiographic images and
guidance tools onto the fluoroscopy screen and may enhance
workflow and improve procedural outcomes. This article will
review the concept, literature, and current use of fusion imag-
ing during various SHD interventions such as valvular repair
or replacement as well as closure of paravalvular leaks or the
left atrial appendage. Although not discussed, the use of this
technology can also be applied to electrophysiology and con-
genital heart disease interventions.
The Challenges During SHD Interventions
SHD interventions are performed with specially designed cath-
eters, guides, sheaths, and implantation tools. To perform suc-
cessful interventions without causing any harm it is mandatory
to use these tools with high precision. One of the challenges
during structural heart interventions is to accurately visualize in
real time the moving catheters and implant material within the
beating heart. In addition, SHD interventions are complex and
numerous guidelines recommend the implementation of a mul-
tidisciplinary SHD team rather than a single person [13–15].
The SHD team typically consists of cardiologists and cardiac
interventionalists, a cardiac surgeon, cardiovascular imaging
specialists, anesthesiologists, and specialized nurses. The action
of the intervening specialists heavily depends on the images
offered by the imaging specialist, who in turn needs to know
the structures relevant to the interventionalist and what views
are optimal for guiding the procedure. To complicate things
further, the orientation of the projected images differs largely
between imaging modalities. While the imaging windows of
the TEE probe are typically limited to a narrow (although not
fixed) view through the esophagus [16], the C-arm rotation in
contrast allows multiple views of the same structure (Fig. 1)
[17]. Thus, identifying structures simultaneously on echocar-
diographic and fluoroscopic imaging becomes complicated and
prone to miscommunication. Furthermore, all imaging tech-
niques have strengths and weaknesses, making the use of mul-
tiple imaging modalities necessary during interventions.
Hence, accurate identification of complex three-
dimensional structures on multiple imaging modalities and
effective communication of this anatomy within the SHD
team become key factors for successful SHD interventions.
To facilitate these tasks, real-time fusion imaging (i.e. fusion
of the most commonly used imaging modalities into one) has
recently been introduced [18, 19•, 20, 21].
Fig. 1 Geometry of the optimal projection curve during fluoroscopy. The
vector joining the X-ray source and the center point of the detector is
designated vd, and the vector pointing along a structure of interest is vs.
a, b The angular system (cranial [CRA]/caudal [CAU] and right anterior
oblique [RAO]/left anterior oblique [LAO] angles) used in fluoroscopy is
described. c All vectors vd perpendicular to vector vs are optimal viewing
angles. The optimal projection curve is the plot of the fluoroscopic angles
of all vectors vd for a particular structure of interest. d The optimal pro-
jection curve is shown for different cardiac structures. Reprinted from
[17] with permission
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The Concept of Fusion Imaging
Fusion of Static Images
Various fusion types of static imaging exist. Fusion of
cardiac MS CT with single photon emission computed
tomography has been used to correlate the coronary ar-
tery anatomy to the area of ischemia [22]. Lately, sim-
ilarly fused images for the identification of ischemic
areas have been achieved combining MS CT and echo-
cardiography [23], different cardiac magnetic resonance
modalities [24], and positron emission tomography
(PET) with coronary angiography [25]. In the diagnostic
workup of prosthetic heart valve infections, fusion of
MS CT angiography with PET has proven helpful
[26]. And for the selection of the correct size and type
of prosthetic heart valve for TAVR, fusion of MS CT
data with models of prosthetic implants has gained pop-
ularity [27]. These types of fusion, however, use two
static images and are therefore not suitable during beat-
ing-heart, real-time SHD interventions.
Fusion of Dynamic Images
For beating-heart interventions, systems fusing real-time im-
ages have been developed. Most systems use rapid CT per-
formed in the hybrid intervention room and superimpose spe-
cific information (markers, overlay images) onto the fluoros-
copy or angiography image (Fig. 2) [19•, 20, 21, 28–30]. The
challenge during this type of hybrid fusion (fusion of a static
with a dynamic image) is motion compensation for the beating
heart and for breathing. This problem has been overcome by a
software called EchoNavigator (Philips Medical Systems,
Best, The Netherlands), which fuses real-time (Blive^) images
from TEE and fluoroscopy [18, 31, 32••].
Real-Time Fusion of Echocardiography and Fluoroscopy
Real-time fusion of two or more cardiac imaging modalities of
the beating heart is not a simple task. The key feature to enable
correct real-time fusion is the co-registration of the echocardi-
ography probe position with the intervention table and the
angulation of the fluoroscopy C-arm [18, 33]. Special
Fig. 2 Fusion of computed
tomography with fluoroscopy.
Fusion of CT and fluoroscopy
images has been used for
interventions such as implantation
of left ventricular leads for cardiac
resynchronization (1, a–c) or for
planning interventions in
congenital heart disease such as
coarctation of the aorta (arrow in
2, a and b). CS, coronary sinus;
RV, right ventricle; RA, right
atrium. Reprinted from [19•, 30]
with permission
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software is needed to recognize the TEE probe within the field
of fluoroscopy view and to align its positionwith that of the C-
arm. Once co-registration is successfully performed, the TEE
probe and the fluoroscopy arm can be moved while image
fusion is maintained (Fig. 3). Markers (dots or crosses) can
be set to highlight important structures on the echocardiogra-
phy image, and they are automatically displayed and updated
in real time on the fluoroscopy image (Fig. 4a). Figure 4b
demonstrates why the default image orientation of different
imaging modalities can be confusing and how overlay imag-
ing assists SHD teams in overcoming such challenges. The
ability to overlay color Doppler images additionally facilitates
the identification of specific targets, improving the rapid, ac-
curate identification of structural lesions.
Use of Real-Time Fusion Imaging in SHD
Interventions
Precise Transseptal Puncture
A targeted, precise, and safe puncture of the interatrial septum
is the first important step for many SHD interventions.
Depending on the procedure type, the puncture site should
be inferoposterior (i.e., for percutaneous closure of the left
atrial appendage [LAA]) or anterosuperior at a level of 4 cm
above the mitral annulus (MitraClip implantation). In the latter
case, the optimal puncture site is identified in the TEE four-
chamber view (or roughly 0°) where the required distance can
easily be measured (Fig. 5a). For the perforation however, the
TEE angle is increased to roughly 45° and the simultaneous
biplane or multiple plane function activated. The bicaval view
is then used as an overlay on top of the fluoroscopy. This
ensures a fast but nevertheless safe and very precise puncture
of the interatrial septum (Fig. 5b).
PFO/ASD Closure
Many centers do not use echocardiographic guidance for pat-
ent foramen ovale (PFO) or atrial septal defect (ASD) closure
[34, 35]. If the PFO channel is however long and rather nar-
row, wire passage can be time consuming. Using a marker on
the fused fluoro-echo image facilitates this passage. In addi-
tion, a PFO and small ASDs can coexist. Without echocardio-
graphic imaging, there is a high likelihood that the wire will
pass the septum in a non-targeted manner. To achieve
Fig. 3 Real-time fusion of echocardiography and X-ray (fluoroscopy).
Co-registration of X-ray and TEE is performed by fluoroscopic acquisi-
tion of the TEE probe in two angulated projections. The algorithm rec-
ognizes the position of the TEE probe by comparing the X-ray data with
the acquired ultra-high-resolution volumes from the 3D model (a). The
four images displayed simultaneously (b–e) by the EchoNavigator sys-
tem are described as follows: b free rotated TEE image: this view can be
freely manipulated by a mouse at the table site. c Echo image: this is the
standard TEE projection as it appears on the echocardiographer’s screen.
d The C-arm gantry view is the echocardiographic image orientated in the
same plane as the X-ray view. e Finally, the fluoroscopy shows the an-
giographic view with the echocardiographic image volume displayed
onto the X-ray view. The yellow arrow indicates the tip of a right ven-
tricular pacemaker lead. RV, right ventricle; LV, left ventricle. Reprinted
from [18] with permission
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Fig. 4 Tools in fusion imaging: markers (a) and overlay imaging (b).
During the MitraClip intervention, the main mitral lesion can be labeled
by the echocardiographer using a marker (red dot placed on the mitral
valve). This marker is automatically demonstrated in real time on the
fluoroscopy image (a). Using the overlay mode (b, showing an atrial
septal defect), the echocardiographic image is overlaid on top of the
fluoroscopy image in the correct position and angulation. The
interventional cardiologist can choose between the purple and the green
echo views given by xPlane echocardiography. In this case, the green
view better demonstrates the anatomy for puncture purposes. The
overlay mode highlights the orientation difficulties that SHD teams face
during an intervention. In the modified TEE bicaval view, the superior
vena cava is located to the right, while the coronary sinus is to the left,
connected by the horizontally orientated interatrial septum. During
fluoroscopy for transseptal puncture, the orientation of the C-arm is most-
ly neutral (in our example, LAO 13.5°, CRAN 0°). This leads to a
completely different orientation: the superior vena cava is cranial, while
the coronary sinus is at the bottom and to the lateral, with a more or less
vertical interatrial septum. SVC, superior vena cava; CS, coronary sinus;
IAS, interatrial septum. Blue arrow: depicting the left ventricular lead in
the CS. a Adapted from Sündermann et al. [32••]
Fig. 5 Correct puncture height (a) and safe passage (b) during transseptal
puncture. During SHD interventions, the height of the transseptal
puncture is often crucial. For the MitraClip procedure, the septum
should be perforated at a distance of 4 cm from the mitral annular
plane. This measurement is best achieved in a four-chamber view at
roughly 0° (marker in a). However, an echo angulation of about 35°/
125° in xPlane best shows the aortic root and the bicaval view, enabling
safe and precise puncture. Using fusion imaging, the precise site chosen
in the four-chamber view is also demonstrated in the aortic root short axis
view (b, marker 1 on echo and overlay image)
Curr Cardiovasc Imaging Rep (2015) 8: 33 Page 5 of 14 33
complete closure, however, anatomic knowledge is mandato-
ry. Overlay image and/or the use of a marker ensure passage of
the correct perforation and lead to complete ASD/PFO clo-
sure. Overlay imaging supports fast and safe deployment of
the Bleft atrial umbrella^ since there is constant control of the
correct position of the sheet orifice within the left atrium
(Fig. 6a, b). Using overlay imaging, this procedure can be
performed without the use of contrast agents (Fig. 6c).
Mitral Valve Interventions
Percutaneous Mitral Valve Repair Using the MitraClip
During MitraClip (MC) intervention, a steerable 24F sheet is
used for the passage of the MC delivery system. Maneuvering
such a device harbors dangers such as accidental puncture of
the aortic root as well as perforation of the left atrial wall.
Precision during the MC procedure is thus key for a safe and
successful intervention, and the use of fusion imaging has
turned this complicated procedure into a safe and effective
one [31]. The first critical step is the targeted transseptal punc-
ture as mentioned above. Once the interatrial septum is perfo-
rated and the sheet in place, steering the MC delivery system
down to the mitral valve can be challenging on two-
dimensional fluoroscopy. Erroneous steering may lead to long
radiation and procedure time and potentially damage the left
atrium free wall. Fusing live 2D and 3D echocardiography
with fluoroscopy is safe and feasible in most patients and
shows a trend towards reduction of fluoroscopy and procedure
time [32••]. The use of the real-time overlay function for
transseptal puncture (Fig. 5) and markers to identify the war-
farin ridge (Fig. 7) as well as the target mitral lesion (Fig. 4a) is
a key step. Real-time overlay imaging can also be used to
guide clip insertion in multiple clip procedures (Fig. 8).
Mitral Paravalvular Leak Closure
Closure of paravalvular mitral regurgitation post mitral valve
surgery can be performed with a transseptal or transapical
approach. The advantage of fusion imaging for the transseptal
approach is described above. For the transapical approach,
identification of the optimal perforation site by echocardiog-
raphy can help to achieve favorable Bangles.^ Fusion of fluo-
roscopy and echocardiography (Fig. 9) or fluoroscopy and
DynaCT (Siemens AG, Forchheim, Germany) [21] has been
used for the transapical approach. Real-time echo/fluoro fu-
sion is used for the identification of the exact location of the
paravalvular leak. This is particularly helpful in the presence
of several leaks (Fig. 9a). Wire passage of the correct leak site
is relatively easy once its location is marked on the fluorosco-
py image (Fig. 9b). Closure of such leaks can be done without
the use of contrast agents, a potentially relevant aspect in these
often severely ill patients with renal insufficiency.
Transcatheter Mitral Valve Replacement
Current options for transcatheter mitral valve replacement in-
clude valve-in-ring (transseptal or transapical approach) and
transapical valve-in-valve treatments [36–38]. The
annuloplasty ring or valve prosthesis can be used as markers
during intervention, and in contrast to the native valve and
annulus, they are visible on fluoroscopy. Hence, fusion imag-
ing is not as important for the placement and release of the
prosthetic valve as it is for interventions in native soft tissue.
Fusion imaging may however be used for choosing the proper
Fig. 6 Fusion imaging guided ASD closure: 2D and 3D real-time TEE
overlay on fluoroscopy. Using fusion imaging, the location of the sheet
orifice is constantly visualized and the left atrial disc is released under
direct vision (a). The right atrial disc is opened under echo-guidance (b).
Color Doppler echocardiography overlay helps to determine correct de-
velopment, localization, and function of the device without the use of
contrast agent (c, different patient than a and b)
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Fig. 7 Fusion imaging may improve safety during SHD procedures. On
the TEE image, a landmark (marker 2) is placed to identify the warfarin
ridge on fluoroscopy (a, b). During the procedure, this critical landmark
may not always be visible on echocardiography. Nevertheless, it is shown
on the fluoroscopy image, with the position updated depending on the C-
arm angulation (c LAO 44°, CRA 9°; d LAO 46°, CRA 12°). Such
markers ensure safe and precise passage of a large catheter through the
interatrial septum (e, marker 1) and may raise caution when approaching
them (f, marker 2)
Fig. 8 Overlay of 3D real-time echocardiography and fluoroscopy dur-
ing a MitraClip procedure. a–c demonstrate step by step the insertion of
clip 1 and 2 (each with 3D real-time echo on top, fusion image at the
bottom). aOrientation of the clip relative to the mitral valve leaflet margin
after clip opening. bResidual moderate mitral regurgitation after insertion
of clip 1 in the medial part of the segments two. A second clip is ap-
proaching the valve. c Residual mild mitral regurgitation with three jets
(denoted with single, double, and triple asterisks) after the insertion of the
second clip
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access site (transseptal puncture and apical perforation
as discussed above). Furthermore, the correct position
and function of the implanted prosthetic valve is usually
controlled by TEE, nicely demonstrated on fusion imag-
ing (Fig. 10).
For the recently introducedmitral valve prostheses that will
be used as percutaneous valve-in-native-valve procedure,
fusion imaging will likely become equally important as with
the MC procedure [37]. During transcatheter mitral valve re-
placement interventions, critical landmarks such as the mitral
annulus or the aorto-mitral connection are not visible on fluo-
roscopy alone. In addition, the orientation of the prosthesis is
of critical importance, and proper alignment will easily be
achieved using the fused images. As this approach is expected
Fig. 9 Fusion imaging during mitral paravalvular leak closure. 3D real-
time echocardiography with and without color Doppler is helpful to de-
termine the exact location and numbers of valvular and paravalvular jets
(a). In this case, jets at 7 and 11 o’clockwere considered the target lesions.
bA red markerwas used to locate the lesion at 11 o’clock (upper image),
guiding the wire passage of the correct leak under fluoroscopy (bottom
image). c The same approach was used to close the lesion at 7 o’clock
with a vascular plug (double asterisks). d Echocardiographic images of
the final result showing vascular plugs (single and double asterisks) at 11
and 7 o’clock, respectively, and a markedly reduced paravalvular and
unchanged transvalvular regurgitation compared to a
Fig. 10 Fusion imaging before (a) and after (b) transapical mitral valve-
in-valve replacement. a Fusion of 3D color Doppler transesophageal
echocardiography with fluoroscopy: a failing 27-mm stented Edwards
bioprosthesis in mitral position with flail of the lateral leaflet, leading to
severe transvalvular mitral regurgitation. b After transapical valve-in-
valve replacement, fusion imaging documents correct position of the
implanted 26-mm Edwards Sapien XT bioprosthesis with complete leaf-
let coaptation and no residual regurgitation. Small inlets show fluorosco-
py alone immediately before (a) and at the end (b) of the implantation of
the Sapien XT prosthesis into the failing bioprosthesis
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to become almost equally relevant as TAVR, there is a great
future for real-time fused imaging in this field.
Aortic Valve Interventions
Transcatheter Aortic Valve Replacement
During TAVR, the valve prosthesis is implanted at the level of
the (often invisible) aortic annulus. Fusion of DynaCTand fluo-
roscopy imaging provides a complete anatomic reference of the
aortic root, including aortic annulus, sinuses of Valsalva, and
coronary artery ostia [21, 39]. This can be demonstrated using
markers (Fig. 11a) or complete overlay (Fig. 11b). Using CTand
fluoroscopy overlay, implantation of the valve prosthesis in an
anatomically correct orientation can be achieved [40••].
The shortcoming of current CT and fluoroscopy overlay is
the inability of live fusion, i.e., there is insufficient motion
compensation for the overlaid CT image. Once this problem
can be solved, CT/fluoro overlay might become an alternative
during TAVR in cases where the injection of contrast agent is
contraindicated.
Aortic Paravalvular Leak Closure
The challenge during closing of paravalvular leaks of aortic
valve prostheses is the generally poor image quality by echo-
cardiography. Extinction of crucial information due to
shadowing by the prosthetic valve is common and especially
prominent in patients with a mechanical prosthesis. While the
metallic core and leaflets of the prosthetic valve can usually be
seen on X-ray, the round structure makes the orientation dif-
ficult. Using markers and real-time overlay imaging facilitates
localizing the perforation site and enables wire passage with-
out the use of contrast. The reduction of aortic regurgitation
after passing the paravalvular leakage with the catheter and
after deployment of the vascular plug is demonstrated imme-
diately (Fig. 12). The correct movement of the prosthetic leaf-
lets can simultaneously be assured on fluoroscopy. Using
proper C-arm angulation, the co-registration of the TEE probe
with the C-arm also works during transgastric TEE.
Left Atrial Appendage Occlusion
During percutaneous closure of the LAA, perforation of the
LAAwall and laceration of the pulmonary artery can lead to
pericardial tamponade and immediate death [41, 42]. The use
of markers is helpful to localize the otherwise invisible LAA
structures on fluoroscopy and prevent catastrophic complica-
tions. Such markers can be placed at the LAA orifice (at the
level of the circumflex artery, Fig. 13a), the orifice of the left
upper pulmonary vein (warfarin ridge), or the tip or bottom of
the LAA. In addition, overlay imaging may help with the
LAA orientation and ensure correct device position (Fig. 13b).
Septal Alcohol Ablation in Hypertrophic
Cardiomyopathy
Left ventricular outflow tract obstruction in hypertrophic car-
diomyopathy can be removed either by surgical resection or
by transcoronary alcohol ablation of septal hypertrophy
Fig. 11 Fusion imaging during TAVR. Fusion imaging during
transfemoral TAVR procedure. Both images show fusion of CT and
fluoroscopy images. a The CT-gained boarders (marked yellow line) of
the aortic root as well as the coronary ostia (green and blue markers)
demonstrate perfect fusion with fluoroscopy. b A similar visualization
is achieved using a semitransparent 3D model of the reconstructed aorta
(based on CT data), overlaid on fluoroscopy. Both modalities enable
deployment of the valvular prosthesis at the correct annular height (red
dots). a Reprinted from [39] with permission
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Fig. 12 Fusion imaging during aortic paravalvular leak closure. aDue to
extensive shadowing inmidesophageal views, the amount of paravalvular
leak can best be visualized in transgastric views (top image). Using proper
C-arm angulation, co-registration of the TEE probe with the C-arm and
hence fusion imaging even works during transgastric imaging (bottom). b
Fusion imaging facilitates the wire and catheter passage through the leak-
age, immediately showing a reduction of aortic regurgitation as Bproof^
of correct passage. cReduced paravalvular regurgitation after deployment
of an Amplatzer Vascular Plug III ®
Fig. 13 Fusion imaging during
percutaneous left atrial appendage
closure. a A marker in the echo
image indicates the landing zone
in the left atrial appendage, with
the corresponding marker in the
fluoroscopy image. b xPlane
echocardiography (top) images
demonstrate proper device
placement in two planes, while
simultaneous overlay imaging
(bottom) ensures correct
deployment and orientation of the
(still attached) Amplatzer Cardiac
Plug ® at the target zone
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(TASH) [43]. During TASH procedure, one of the most im-
portant steps is the identification of the septal branch perfusing
the basal part of the hypertrophic septum. This can be straight-
forward in cases where one single branch is identified but
more challenging when multiple small braches are present.
In the case of several branches, the correlation between the
branch and the septal muscle area can be nicely demonstrated
by overlay imaging (Fig. 14).
Fig. 14 Fusion imaging during transcoronary ablation of septal
hypertrophy (TASH). Fusion imaging during alcohol ablation of the
second (a, b) and first (c–e) septal branch. a Wire (blue arrow) in the
second branch after septal alcohol ablation, with the corresponding
demarcated area (blue dashed circle). This however led to insufficient
reduction of left ventricular outflow tract obstruction, as demonstrated
by color Doppler imaging (mitral regurgitation due to systolic anterior
motion, blue arrow head in b). c Placement of the wire into the first septal
branch (red arrow), corresponding with a septal area (red dashed circle)
just proximal to that of the second septal branch (blue dashed circle). d
Demarcation of the proximal septum (red dashed circle) after alcohol
infusion into the first branch. e Sufficient reduction of left ventricular
outflow tract obstruction, demonstrated by markedly reduced mitral
regurgitation an flow acceleration
Fig. 15 The future of fusion imaging. The future of fusion imaging for
simulation and guidance of structural heart disease interventions. a
Prototype software enables segmentation of relevant anatomical
structures, such as the inferior vena cava or the interatrial septum.
Ideally, a potential catheter could then be integrated into the image and
determine the optimal perforation site in this patient (red arrow
highlighting red cross). b Using motion compensation, this information
should then be overlaid onto the real-time fusion of echo and fluoroscopy,
potentially enabling a truly targeted and precise intervention. Please note:
this figure was created by Bfusing^ images of two different existing soft-
ware systems (B3mensio Structural Heart^ and BEchoNavigator^), but
does not represent currently available software. Reproduced with permis-
sion from 3mensio®
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Limitation of Available Data on Fusion Imaging
This review on how to best use fusion imaging during differ-
ent SHD interventions is largely based on the authors’ expe-
rience. This has two reasons: (1) until very recently, there was
only one operation system commercially available for real-
time fusion between dynamic images, and this system was
installed only in very few hospitals. (2) As a consequence,
there is very little data (in particular no randomized trial)
proving the superiority of fusion imaging over the standard
approach [32••]. Hence, whether the use of fusion imaging
leads to a reduction of radiation dose, faster and safer inter-
ventions, and higher interventional success rates remains to be
seen.
Future Role of Fusion Imaging
Due to the constantly aging population in Western countries,
aortic and mitral valve replacement therapies will be the lead-
ing interventions in SHD. As there is trend to expand percu-
taneous procedures to an intermediate or even low-risk popu-
lation, procedural efficacy and safety will become even more
important. This can only be achieved if all SHD team mem-
bers dispose of an expert understanding of the three-
dimensional structures of the heart and of fusion imaging
techniques showing this anatomy in real time.
There is also room for improvement. Some anatomical
structures are not well depicted by the current versions of
real-time fusion. These include the irregularly shaped atria,
the pulmonary valve and artery, as well as the left atrial ap-
pendage. In the near future, we expect increasing clinical im-
portance of more advanced fusion imaging, such as overlay of
static (but motion compensated), semitransparent three-
dimensional low-dose CT images of the atria on fluoroscopy
and echocardiography. Increasing computing capacities and
more dedicated software will likely allow the use of real-
time computer models simulating SHD interventions (i.e.,
simulation of the optimal [really targeted] septal puncture site,
Fig. 15a) and overlaying such information during the actual
intervention (Fig. 15b). Similar benefits could potentially be
achieved for simulation of soft tissue reaction to deployment
of prosthetic material, including deformation of mitral annulus
during percutaneous mitral valve replacement, change in mi-
tral valve geometry and residual mitral orifice area duringMC
interventions, or translocation of calcium and thus deforma-
tion of the aortic annulus during TAVR.
Conclusion
Fusion of different imaging modalities has gained increasing
popularity over the last decade. In order to adequately
visualize complex three-dimensional cardiac structures, the
beating heart asks for high-temporal and spatial image resolu-
tions. Currently, only the combination of transesophageal
echocardiography with fluoroscopy allows real-time image
fusion of good quality during SHD interventions. The use of
markers as well as real-time image overlay greatly facilitates
communication between SHD team members and potentially
increases procedural success while reducing radiation dose,
procedure time, and contrast use. However, to date there is
only limited evidence that fusion imaging improves safety
and outcomes of SHD interventions.
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